News Agency
Men's Weekly

Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

  • Written by PR Newswire
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

MELBOURNE, Australia and INDIANAPOLIS, April 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Company ("Lilly") under which Telix is granted exclusive worldwide rights to develop and commercialise radiolabelled forms of Lilly's...

Read more: Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

Why Defence Recruitment Plays A Key Role In Supporting The Defence Industry

The defence sector is a vital part of national security and technological development. It supports military operations, research programs, and strategic planning that help protect national interests. As the defence sector continues to evolve, organisations rely on specialised hiring processes... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion